Influenza vaccination far from the target set by MS in Masic

The first phase of the influenza vaccination campaign has, so far, reached 17,182 people in Maceió. The capital expects to vaccinate at least 90% of each of its priority groups: seniors aged 60 or over and health workers. However, Maceo is far from achieving the goal. The first phase of immunization ends on April 30, when the campaign’s D-Day begins. On May 2, a new stage will begin serving children from 6 months to less than 5 years old – 4 years, 11 months and 29 days.

According to the Maceio Municipal Health Department (SMS), as of the 22nd, 12,297 doses of influenza vaccine have been administered to the elderly, which is 9.9% of the estimated audience; and 4,885 doses in health workers, which is 11.4% of the recommended audience.

The influenza vaccination campaign has been available in all health units since April 4 for priority groups recommended by the Ministry of Health (MS).

For immunization, residents must present a photo identification document in addition to the vaccination card. Health workers must also provide an original and a copy of documents evidencing their current professional practice, such as, for example, a class board card, badge, updated salary, or a statement from the health institution in which they work or carry out an internship. Copies of these vouchers will be kept by the vaccination team.

The second stage of vaccination

The second phase of the campaigns will take place between May 2 and June 3. At this point, immunization against influenza and measles serves children from the age of 6 months to less than 5 years. In the second phase, pregnant and postpartum women, teachers, people with comorbidities, people with permanent disabilities, professionals from the security and rescue forces, the armed forces, truck drivers and urban and long-distance workers, port workers, prison system personnel, adolescents and young adults from ages 12 to 21 general population who are subject to socio-educational measures, as well as to the population deprived of their liberty.

Trivalent Vaccine

The Trivalent Influenza Vaccine used by the Unified Health System (SUS) is produced by the Putantan Institute. The composition is constantly updated so that the dose is effective in protecting against new strains of the virus. The vaccine will be effective against H1N1, H3N2 and type B strains.

Children

In the case of children aged six months and less than 5 years, who have already received at least one dose of influenza vaccine throughout their lives in previous years, the schedule of vaccination with only one dose should be considered in 2022. Vaccination will take place for the first time, the direction is to determine The second dose of the flu vaccine is scheduled for 30 days after the first dose.